Comparison of iopamidol with metrizamide in sub-occipital ventriculography/cisternography
P. Macpherson, E. Teasdale
Abstract
P. Macpherson, E. Teasdale
Abstract
In the near future, new non-ionic contrast media will become available for use in the examination of the basal cisterns and ventricles of the brain. Because metrizamide has become the established contrast medium for these examinations (Grepe, 1975; Hall & McAllister, 1980) any new compound will have to show advantage in respect of better radiological contrast, fewer side effects or lower cost to justify its use. In this study we have compared the new non-ionic medium iopamidol (B15000) with metrizamide.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In the near future, new non-ionic contrast media will become available for use in the examination of the basal cisterns and ventricles of the brain. Because metrizamide has become the established contrast medium for these examinations (Grepe, 1975; Hall & McAllister, 1980) any new compound will have to show advantage in respect of better radiological contrast, fewer side effects or lower cost to justify its use. In this study we have compared the new non-ionic medium iopamidol (B15000) with metrizamide.
Key concepts: Metrizamide, Iopamidol, Cistern, Contrast medium, Medicine, Cerebral Ventriculography, Nuclear medicine, Radiology